ALC
Alcon Inc. · Healthcare · Medical - Specialties
Señales de momentum (gestores comparables):
amplitud de titulares +15.4% ·
flujo de acciones +23.1% ·
nuevas posiciones netas +13.3%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 127 | 0 | 163.73M | $10.99B | +8 | −7 |
| Q1 2026 | 128 | -2 | 149.67M | $11.22B | +4 | −7 |
| Q4 2025 | 130 | +1 | 168.20M | $13.30B | +2 | — |
| Q3 2025 | 18 | +1 | 56.88M | $4.25B | +3 | −3 |
| Q2 2025 | 15 | -4 | 57.20M | $5.06B | — | −4 |
| Q1 2025 | 16 | +1 | 22.35M | $2.11B | +1 | — |
| Q4 2024 | 15 | +2 | 21.30M | $1.81B | +3 | −1 |
| Q3 2024 | 12 | 0 | 17.31M | $1.73B | +2 | −2 |
| Q2 2024 | 12 | — | 18.62M | $1.66B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Norges Bank ✦ (pasivo) | 12.62M | +5.0% | $1.07B | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | Marshall Wace ✦ | 4.08M | +15.7% | $346.35M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 3 | Marshall Wace ✦ | 4.08M | +15.7% | $346.35M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 4 | Marshall Wace ✦ | 4.08M | +15.7% | $346.35M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 4.08M | +15.7% | $346.35M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.54M | Nuevo | $130.92M | 0.1% | New | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.54M | Nuevo | $130.92M | 0.1% | New | 1 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 1.09M | Nuevo | $92.20M | 0.3% | New | 1 | SEC ↗ |
| 9 | PRIMECAP Management ✦ | 776.30K | -1.5% | $65.90M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 296.84K | +34.5% | $25.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 296.84K | +34.5% | $25.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 281.02K | Nuevo | $23.86M | 0.0% | New | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 237.41K | +29.0% | $20.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 237.41K | +29.0% | $20.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 237.41K | +29.0% | $20.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 237.41K | +29.0% | $20.15M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 212.76K | +592.4% | $18.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 85.12K | +51.4% | $7.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 85.12K | +51.4% | $7.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Millennium Management ✦ | 58.70K | -72.9% | $4.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 7.40K | -96.8% | $628,156 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | State Street Global Advisors ✦ (pasivo) | 6.12K | — | $519,781 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 4.78K | -66.6% | $405,689 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 4.49K | +10.8% | $380,974 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 4.49K | +10.8% | $380,974 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 4.49K | +10.8% | $380,974 | 0.0% | ▲ Add | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Citadel Advisors | $130.92M | 0.1% |
| Citadel Advisors | $130.92M | 0.1% |
| Point72 Asset Management | $92.20M | 0.3% |
| Adage Capital Partners | $23.86M | 0.0% |
Posición cerrada
| Two Sigma Investments | $809,566 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 2 tenedores, 868.08K acciones, $64.02M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.